|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,430,000,000 |
Market
Cap: |
104.63(B) |
Last
Volume: |
8,786,292 |
Avg
Vol: |
8,469,733 |
52
Week Range: |
$48.64 - $73.26 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 297 |
Guru Rank Value : 4.1 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
86,763 |
367,796 |
891,893 |
1,852,495 |
Total Sell Value |
$5,815,387 |
$21,391,604 |
$49,075,093 |
$90,475,166 |
Total People Sold |
6 |
8 |
11 |
13 |
Total Sell Transactions |
9 |
19 |
36 |
69 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Phalen Michael P. |
EVP & President, MedSurg |
|
2014-02-28 |
4 |
D |
$13.10 |
$85,294 |
D/D |
(6,511) |
138,129 |
|
- |
|
Phalen Michael P. |
EVP & President, MedSurg |
|
2014-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,792 |
144,640 |
|
- |
|
Pierce David A |
SVP and President, Endoscopy |
|
2014-02-28 |
4 |
D |
$13.10 |
$33,706 |
D/D |
(2,573) |
53,306 |
|
- |
|
Pierce David A |
SVP and President, Endoscopy |
|
2014-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,889 |
55,879 |
|
- |
|
Mirviss Jeffrey B. |
SVP&Pres, Periph Intervent |
|
2014-02-28 |
4 |
D |
$13.10 |
$34,833 |
D/D |
(2,659) |
67,436 |
|
- |
|
Mirviss Jeffrey B. |
SVP&Pres, Periph Intervent |
|
2014-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,911 |
70,095 |
|
- |
|
Onuscheck John Michael |
SVP & President, Europe |
|
2014-02-27 |
4 |
D |
$13.30 |
$53,759 |
D/D |
(4,042) |
99,077 |
|
- |
|
Onuscheck John Michael |
SVP & President, Europe |
|
2014-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,962 |
103,119 |
|
- |
|
Mirviss Jeffrey B. |
SVP&Pres, Periph Intervent |
|
2014-02-27 |
4 |
D |
$13.30 |
$10,680 |
D/D |
(803) |
62,184 |
|
- |
|
Mirviss Jeffrey B. |
SVP&Pres, Periph Intervent |
|
2014-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,388 |
62,987 |
|
- |
|
Fitzgerald Joseph Michael |
EVP & President, CRM |
|
2014-02-27 |
4 |
D |
$13.30 |
$44,489 |
D/D |
(3,345) |
111,692 |
|
- |
|
Fitzgerald Joseph Michael |
EVP & President, CRM |
|
2014-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,952 |
115,037 |
|
- |
|
Dawkins Keith D |
EVP, Global Chief Med. Off. |
|
2014-02-27 |
4 |
D |
$13.30 |
$37,985 |
D/D |
(2,856) |
116,075 |
|
- |
|
Dawkins Keith D |
EVP, Global Chief Med. Off. |
|
2014-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,758 |
118,931 |
|
- |
|
Lance Jean Fitterer |
SVP & Chief Compliance Officer |
|
2014-02-27 |
4 |
D |
$13.30 |
$35,591 |
D/D |
(2,676) |
117,477 |
|
- |
|
Lance Jean Fitterer |
SVP & Chief Compliance Officer |
|
2014-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,962 |
120,153 |
|
- |
|
Carruthers Wendy |
SVP, Human Resources |
|
2014-02-27 |
4 |
D |
$13.30 |
$20,017 |
D/D |
(1,505) |
27,174 |
|
- |
|
Carruthers Wendy |
SVP, Human Resources |
|
2014-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,618 |
28,679 |
|
- |
|
Nanavaty Maulik |
SVP & Pres, Neuromodulation |
|
2014-02-27 |
4 |
D |
$13.30 |
$31,854 |
D/D |
(2,395) |
97,556 |
|
- |
|
Nanavaty Maulik |
SVP & Pres, Neuromodulation |
|
2014-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,369 |
99,951 |
|
- |
|
Brennan Daniel J. |
EVP and CFO |
|
2014-02-27 |
4 |
D |
$13.30 |
$21,586 |
D/D |
(1,623) |
91,171 |
|
- |
|
Brennan Daniel J. |
EVP and CFO |
|
2014-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,976 |
92,794 |
|
- |
|
Ballinger Kevin J. |
SVP & Pres, Interven Cardio |
|
2014-02-27 |
4 |
D |
$13.30 |
$14,244 |
D/D |
(1,071) |
26,828 |
|
- |
|
Ballinger Kevin J. |
SVP & Pres, Interven Cardio |
|
2014-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,185 |
27,899 |
|
- |
|
Pratt Timothy A. |
EVP, GC & Chief Admin Officer |
|
2014-02-27 |
4 |
D |
$13.30 |
$84,987 |
D/D |
(6,390) |
197,459 |
|
- |
|
1824 Records found
|
|
Page 3 of 73 |
|
|